My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Clearmind Medicine Inc. - Common Shares (NQ:CMND)

0.1143 -0.0074 (-6.08%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 10, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Clearmind Medicine Inc. - Common Shares

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Why Is Virgin Orbit (VORB) Stock Down 27% Today? ↗

April 11, 2023

Virgin Orbit (VORB) stock is falling on Tuesday after the space travel company received a delisting notice from the Nasdaq Exchange.

Via InvestorPlace

Why Is PLx Pharma (PLXP) Stock Down 38% Today? ↗

April 11, 2023

PLx Pharma (PLXP) stock is taking a beating on Tuesday and there's a couple of reasons investors will want to know about its fall.

Via InvestorPlace

Why Is Clearmind Medicine (CMND) Stock Up 56% Today? ↗

April 11, 2023

Clearmind Medicine (CMND) stock is taking off on Tuesday with heavy trading despite a lack of news concerning the psychedelics company.

Via InvestorPlace

Why National CineMedia Shares Are Trading Higher By Around 111%; Here Are 20 Stocks Moving Premarket ↗

April 11, 2023

Gainers National CineMedia, Inc. (NASDAQ: NCMI) jumped 111.2% to $0.2810 in pre-market trading after a 13G filing showed a 9.1% passive stake in the company from AMC Entertainment.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

April 11, 2023

We're starting off the day with a breakdown of the biggest pre-market stock movers traders will want to keep an eye on Tuesday!

Via InvestorPlace

Aegis Capital Corp. acted as Exclusive Placement Agent on a $3.5 Million Public Offering for Clearmind Medicine Inc. (NASDAQ: CMND)

April 10, 2023

Via ACCESSWIRE

Clearmind Medicine Closes US$3.5 Million Public Offering

April 06, 2023

From Clearmind Medicine Inc.

Via GlobeNewswire

How To Finance A Psychedelics Business? Learn From These Four Companies ↗

April 04, 2023

Clearmind Medicine Announces Pricing of $3.5 Million Public Offering

Via Benzinga

Dow Tumbles Over 200 Points; Butterfly Network Shares Spike Higher ↗

April 04, 2023

U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping more than 200 points on Tuesday. The Dow traded down 0.64% to 33,387.61 while the NASDAQ fell 0.45% to 12,134.09. The S&P...

Via Benzinga

Why Bullfrog AI Holdings Shares Are Trading Higher By 73%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

April 04, 2023

Gainers Secoo Holding Limited (NASDAQ: SECO) shares surged 138% to $1.43.

Via Benzinga

Gold Rises Sharply; AMC Entertainment Shares Plunge ↗

April 04, 2023

U.S. stocks traded lower midway through trading, with the Dow Jones dropping around 150 points on Tuesday. The Dow traded down 0.46% to 33,447.10 while the NASDAQ fell 0.30% to 12,152.44. The S&P 500,...

Via Benzinga

Why Clearmind Medicine Shares Are Nosediving ↗

April 04, 2023

Clearmind Medicine Inc (NASDAQ: CMND) shares are trading lower by 60.1% to $0.57 Tuesday morning after the company announced a $3.5 million public offering priced at $0.78 per share. The offering is...

Via Benzinga

Clearmind Medicine Announces Pricing of US$3.5 Million Public Offering

April 04, 2023

From Clearmind Medicine Inc.

Via GlobeNewswire

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

April 04, 2023

It's time to dive into the biggest pre-market stock movers for Tuesday morning with all the latest news traders need to know about!

Via InvestorPlace

Psyched: 22 States With Reform Bills, Ketamine Therapy Services Today, Oscars On Shrooms & More ↗

March 20, 2023

Psychedelics Reform Update: 22 States Where Proposals Are Being Discussed & Local Moves Considered

Via Benzinga

A Drug That Mimics Alcohol Buzz Is Bound For Human Trials: Here's What's Next ↗

March 17, 2023

Israeli biotech Clearmind Medicine Inc. (NASDAQ: CMND) has submitted an Investigational New Drug (IND) application with the FDA towards approval to commence its first-in-human Phase 1/2a clinical trial...

Via Benzinga

Clearmind Medicine Submits IND Application to FDA for its Proprietary CMND-100 Treating Alcohol Use Disorder

March 16, 2023

From Clearmind Medicine Inc.

Via GlobeNewswire

Clearmind Medicine Appoints Professor Henry R. Kranzler, M.D., to Scientific Advisory Board

March 14, 2023

From Clearmind Medicine Inc.

Via GlobeNewswire

US Stocks Mostly Higher; Dow Rises 75 Points ↗

March 13, 2023

U.S. stocks traded mostly higher this morning, with the Dow Jones gaining around 75 points on Monday. Following the market opening Monday, the Dow traded up 0.24% to 31,986.55 while the NASDAQ rose...

Via Benzinga

Why Bank Shares Are Trading Lower? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

March 13, 2023

Gainers Provention Bio, Inc. (NASDAQ: PRVB) shares jumped 250.8% to $23.50 after Sanofi announced it will acquire the company for $25 per share in cash.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

March 13, 2023

We're starting off the week with a breakdown of the biggest pre-market stock movers traders need to know about for Monday!

Via InvestorPlace

Here Are The Year's Highest Priced Psychedelics Stocks In US Markets ↗

March 06, 2023

After everything that's happened in the last several years, we believe it's safe to say that the psychedelic renaissance is a reality, one that Benzinga has consistently reported on.

Via Benzinga

Psyched: Hawaii And Minnesota's Bills, Studying 2C-B Vs. Psilocybin, Filament CEO, Plus Brock Pierce And Jeremy Gardner Discuss The Industry's Future And More ↗

February 27, 2023

Two Bills Approved By Hawaii Senators With Governor's Endorsement Hawaii Senate Ways and Means Committee approved a pair of bills aiming to promote and investigate the therapeutic potential of MDMA and...

Via Benzinga

SciSparc And Clearmind Reveal Three Unique Combinations Of Future Psychedelic-Based Compounds ↗

February 22, 2023

SciSparc Ltd. (NASDAQ: SPRC), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, announced that as part of its...

Via Benzinga

SciSparc and Clearmind Reveal Three Unique Combinations of Future Psychedelic-Based Compounds

February 22, 2023

Clearmind Medicine submitted patent applications to protect the novel compounds

From SciSparc Ltd

Via GlobeNewswire

Israel-Based Clearmind Medicine Files Patent Applications for Three Unique Combinations of Future Psychedelic-Based Compounds

February 22, 2023

From Clearmind Medicine Inc.

Via GlobeNewswire

Novel Combination Of Cannabis-Like Compound With Classical Psychedelics Searches IP Coverage In US ↗

February 15, 2023

Israeli-based next-gen psychedelics biotech Clearmind Medicine (NASDAQ: CMND) together with partner clinical-stage pharma company SciSparc (NASDAQ: SPRC) has filed three provisional patent applications...

Via Benzinga

SciSparc and Clearmind Collaboration Strengthens IP Portfolio with Three Provisional Patent Applications in the US

February 15, 2023

From SciSparc Ltd

Via GlobeNewswire

Israel-Based Clearmind Medicine Strengthening IP Portfolio with Three Provisional Patent Applications in the US

February 15, 2023

From Clearmind Medicine Inc.

Via GlobeNewswire

Israel-Based Clearmind Medicine to Present at The OurCrowd Global Investor Summit Sponsored by Greenberg Traurig Tel Aviv

February 14, 2023

From Clearmind Medicine Inc.

Via GlobeNewswire

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.